These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33610748)

  • 41. A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly.
    Xi J; Gu Z; Sun C; Chen Z; Zhang T; Chen R; Liu T; Liao H; Zou J; Yang D; Xu Q; Wang J; Wei G; Cheng Z; Lu F; Chen X
    Antiviral Res; 2023 Oct; 218():105715. PubMed ID: 37683938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel non-HAP class A HBV capsid assembly modulators have distinct
    Vanrusselt H; Kum DB; Taverniti V; Liu C; Acosta Sanchez A; Corthout N; Munck S; Baumert TF; Beigelman L; Blatt LM; Symons JA; Deval J; Raboisson P; Verrier ER; Jekle A; Vendeville S; Debing Y
    J Virol; 2023 Oct; 97(10):e0072223. PubMed ID: 37754761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Dynamics Simulations to Determine the Structure and Dynamics of Hepatitis B Virus Capsid Bound to a Novel Anti-viral Drug.
    Watanabe G; Sato S; Iwadate M; Umeyama H; Hayakawa M; Murakami Y; Yoneda S
    Chem Pharm Bull (Tokyo); 2016; 64(9):1393-6. PubMed ID: 27581644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection.
    Ko C; Bester R; Zhou X; Xu Z; Blossey C; Sacherl J; Vondran FWR; Gao L; Protzer U
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulators.
    Wang S; Ren Y; Li Q; Wang Y; Jiang X; Xu S; Zhang X; Zhao S; Bradley DP; Woodson ME; Zhao F; Wu S; Li Y; Tian Y; Liu X; Tavis JE; Zhan P
    Bioorg Chem; 2022 Dec; 129():106192. PubMed ID: 36265355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
    Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
    ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of New Hepatitis B Virus Capsid Assembly Modulators by an Optimal High-Throughput Cell-Based Assay.
    Pei Y; Wang C; Ben H; Wang L; Ma Y; Ma Q; Xiang Y; Zhang L; Liu G
    ACS Infect Dis; 2019 May; 5(5):778-787. PubMed ID: 30761887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small Molecule Inhibitors of Hepatitis B Virus Nucleocapsid Assembly: A New Approach to Treat Chronic HBV Infection.
    Yang L; Lu M
    Curr Med Chem; 2018; 25(7):802-813. PubMed ID: 28675991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in the development of HBV capsid assembly modulators.
    Nijampatnam B; Liotta DC
    Curr Opin Chem Biol; 2019 Jun; 50():73-79. PubMed ID: 30952041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BAY 41-4109-mediated aggregation of assembled and misassembled HBV capsids in cells revealed by electron microscopy.
    Rat V; Seigneuret F; Burlaud-Gaillard J; Lemoine R; Hourioux C; Zoulim F; Testoni B; Meunier JC; Tauber C; Roingeard P; de Rocquigny H
    Antiviral Res; 2019 Sep; 169():104557. PubMed ID: 31302151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives.
    Yang L; Liu F; Tong X; Hoffmann D; Zuo J; Lu M
    ACS Infect Dis; 2019 May; 5(5):713-724. PubMed ID: 30896149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D-QSAR and molecular dynamics.
    Tu J; Li JJ; Shan ZJ; Zhai HL
    Antiviral Res; 2017 Jan; 137():151-164. PubMed ID: 27908829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection.
    Cole AG
    Curr Opin Pharmacol; 2016 Oct; 30():131-137. PubMed ID: 27636324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and evaluation of highly potent HBV capsid assembly modulators (CAMs).
    Amblard F; Chen Z; Wiseman J; Zhou S; Liu P; Salman M; Verma K; Azadi N; Downs-Bowen J; Tao S; Kumari A; Zhang Q; Smith DB; Patel D; Bassit L; Schinazi RF
    Bioorg Chem; 2023 Dec; 141():106923. PubMed ID: 37871391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations.
    Wang XY; Wei ZM; Wu GY; Wang JH; Zhang YJ; Li J; Zhang HH; Xie XW; Wang X; Wang ZH; Wei L; Wang Y; Chen HS
    Antivir Ther; 2012; 17(5):793-803. PubMed ID: 22668794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents.
    Kim W; Kang JA; Park M; Jeong PH; Kim YJ; Cho Y; Park SG; Kim YC
    J Med Chem; 2021 May; 64(9):5500-5518. PubMed ID: 33887912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents.
    Amblard F; Boucle S; Bassit L; Chen Z; Sari O; Cox B; Verma K; Ozturk T; Ollinger-Russell O; Schinazi RF
    Bioorg Med Chem; 2021 Feb; 31():115952. PubMed ID: 33421915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The interface between hepatitis B virus capsid proteins affects self-assembly, pregenomic RNA packaging, and reverse transcription.
    Tan Z; Pionek K; Unchwaniwala N; Maguire ML; Loeb DD; Zlotnick A
    J Virol; 2015 Mar; 89(6):3275-84. PubMed ID: 25568211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.
    Ruan L; Hadden JA; Zlotnick A
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. All-Atom MD Simulations of the HBV Capsid Complexed with AT130 Reveal Secondary and Tertiary Structural Changes and Mechanisms of Allostery.
    Pérez-Segura C; Goh BC; Hadden-Perilla JA
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33810481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.